دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of Contents
doi : 10.1016/S0923-7534(21)04754-2
Volume 32, Issue 12, December 2021, Pages i-ii
Adjuvant abemaciclib for high-risk breast cancer: the story continues
L.Spring1A.Matikas23A.Bardia1T.Foukakis23
PARP inhibitor sensitivity in BRCA-related metastatic breast cancer: an OlympiAD later
J.Fuentes-Antrás12D.W.Cescon12
Acquired resistance in NSCLC: the journey from clinical definition to molecular understanding
E.Wauters12J.Vansteenkiste12
ESMO guidelines on renal cell carcinoma: the paradox of the fine line that separates scientific robustness from cost-efficiency analysis
E.Grande1B.Escudier2
The ESMO-EURACAN-GENTURIS-ERNPaedCan Clinical Practice Guidelines for bone sarcomas – the challenges of the fight against rare cancers
D.Andreou
Liquid biopsy in neuro-oncology: are we finally there?
M.Fontanilles12M.Sanson3M.Touat3
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
A.Gennari1F.André2C.H.Barrios3J.Cortés4567E.de Azambuja8A.DeMichele9R.Dent10D.Fenlon11J.Gligorov12S.A.Hurvitz1314S.-A.Im15D.Krug16W.G.Kunz17S.Loi18F.Penault-Llorca19J.Ricke217M.Robson20H.S.Rugo21…N.Harbeck31
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
T.Yoshino1G.Argilés2E.Oki3E.Martinelli4H.Taniguchi1D.Arnold5S.Mishima1Y.Li6B.K.Smruti7J.B.Ahn8I.Faud9C.E.Chee10K.-H.Yeh1112P.-C.Lin13C.Chua14H.H.Hasbullah15M.A.Lee16A.Sharma17…G.Pentheroudakis28
ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma
T.Powles1L.Albiges2A.Bex34V.Grünwald5C.Porta67G.Procopio8M.Schmidinger9C.Suárez10G.de Velasco11ESMO Guidelines Committee
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
S.J.Strauss1†A.M.Frezza2†N.Abecassis3J.Bajpai4S.Bauer5R.Biagini6S.Bielack7J.Y.Blay8S.Bolle9S.Bonvalot10I.Boukovinas11J.V.M.G.Bovee12K.Boye13B.Brennan14T.Brodowicz15A.Buonadonna16E.de �lava1718A.P.Dei Tos19…S.Stacchiotti2‡
Therapeutic cancer vaccines revamping: technology advancements and pitfalls
G.Antonarelli12C.Corti12P.Tarantino12L.Ascione12J.Cortes34P.Romero5E.A.Mittendorf67M.L.Disis8G.Curigliano12
The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviews
R.J.Chan12M.Crichton13F.Crawford-Williams12O.A.Agbejule12K.Yu4N.H.Hart1256F.de Abreu Alves7F.D.Ashbury89L.Eng1011M.Fitch12H.Jain13M.Jefford141516D.Klemanski17B.Koczwara18K.Loh19M.Prasad20H.Rugo21E.Soto-Perez-de-Celis22…A.Chan24
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
N.Harbeck1†P.Rastogi2†M.Martin3S.M.Tolaney4Z.M.Shao5P.A.Fasching6C.S.Huang7G.G.Jaliffe8A.Tryakin9M.P.Goetz10H.S.Rugo11E.Senkus12L.Testa13M.Andersson14K.Tamura15L.Del Mastro1617G.G.Steger18H.Kreipe19…S.L.Graff
Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: OlympiAD
D.Hodgson1Z.Lai1S.Dearden2J.C.Barrett1E.A.Harrington2K.Timms3J.Lanchbury3W.Wu4A.Allen4E.Senkus5S.M.Domchek6M.Robson7
Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial
A.Llop-Guevara1S.Loibl2G.Villacampa1V.Vladimirova2A.Schneeweiss3T.Karn4D.-M.Zahm5A.Herencia-Ropero1P.Jank6M.van Mackelenbergh7P.A.Fasching8F.Marmé9E.Stickeler10C.Schem11R.Dienstmann1S.Florian12V.Nekljudova2J.Balmaña1…V.Serra1
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer
A.J.Schoenfeld12S.J.Antonia3M.M.Awad4E.Felip5J.Gainor67S.N.Gettinger8F.S.Hodi4M.L.Johnson9N.B.Leighl10C.M.Lovly11T.Mok12M.Perol13M.Reck14B.Solomon15J.-C.Soria16D.S.W.Tan17S.Peters18†M.D.Hellmann1â€
The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and liquid biopsy approaches
P.Billard12C.Guerriau1C.Carpentier3F.Juillard4N.Grandin5P.Lomonte4P.Kantapareddy6N.Dufay6M.Barritault1R.Rimokh7P.Verrelle5D.Maucort-Boulch8D.Figarella-Branger910F.Ducray711C.Dehais12M.Charbonneau5D.Meyronet17D.A.Poncet12the POLA network
Lesion-level heterogeneity of radiologic progression in patients treated with pembrolizumab
B.G.Topp1K.Thiagarajan2D.P.De Alwis1A.Snyder3M.D.Hellmann4
Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project
D.M.Vega1L.M.Yee2L.M.McShane2P.M.Williams3L.Chen3T.Vilimas3D.Fabrizio4V.Funari5J.Newberg4L.K.Bruce5S.-J.Chen6J.Baden7J.Carl Barrett8P.Beer9M.Butler10J.-H.Cheng6J.Conroy11D.Cyanam12…J.Allen1
Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy
J.Remon1†J.-C.Soria2†S.Peters3ESMO Guidelines Committee
Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients
M.Aldea12L.Cerbone1A.Bayle2C.Parisi1C.Sarkozy2D.Vasseur3L.Verlingue2F.Blanc-Durand1F.Mosele1M.Sakkal12S.Ponce2P.Lavaud1Y.Loriot1A.Hollebecque2C.Massard2J.-C.Soria24L.Lacroix3E.Rouleau3A.Italiano25
VP8-2021: Adjuvant abemaciclib combined with endocrine therapy (ET): Updated results from monarchE
J.O'Shaughnessy1P.Rastogi2N.Harbeck3M.Toi4R.Hegg5J.Sohn6V.Guarneri7J.Cortes8E.Hamilton9R.Wei10A.Shahir10B.San Antonio10S.C.Nabinger10S.Tolaney11M.Martin12S.R.D.Johnston13
Corrigendum to ‘First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis’: Annals of Oncology 2021; 32: 983-993
L.A.Emens1S.Adams2C.H.Barrios3V.Diéras4H.Iwata5S.Loi6H.S.Rugo7A.Schneeweiss8E.P.Winer9S.Patel10V.Henschel11A.Swat12M.Kaul13L.Molinero14S.Patel15S.Y.Chui10P.Schmid16
